東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Interleukins." ]

切換: 標籤 | MARC模式 | ISBD

Targeting the IL-17 pathway in infla...

Chu, Cong-Qiu.

FindBook

Google Book

Amazon

博客來

Targeting the IL-17 pathway in inflammatory disorders

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Targeting the IL-17 pathway in inflammatory disorders/ by Cong-Qiu Chu.
作者:	Chu, Cong-Qiu.
出版者:	Cham :Springer International Publishing : : 2017.,
面頁冊數:	xv, 102 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Interleukins. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-28040-0
ISBN:	9783319280400

Targeting the IL-17 pathway in inflammatory disorders
Chu, Cong-Qiu.

Targeting the IL-17 pathway in inflammatory disorders[electronic resource] /by Cong-Qiu Chu. - Cham :Springer International Publishing :2017. - xv, 102 p. :ill., digital ;24 cm.

This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.

ISBN: 9783319280400

Standard No.: 10.1007/978-3-319-28040-0doiSubjects--Topical Terms:

2194691
Interleukins.

LC Class. No.: QR185.8.I56

Dewey Class. No.: 571.96

Targeting the IL-17 pathway in inflammatory disorders
LDR:01685nmm a2200301 a 4500 001 2088675
003 DE-He213
005 20161128200532.0
006 m d
007 cr nn 008maaau
008 171013s2017 gw s 0 eng d
020 $a 9783319280400 $q (electronic bk.)
020 $a 9783319280394 $q (paper)
024 7 $a 10.1007/978-3-319-28040-0 $2 doi
035 $a 978-3-319-28040-0
040 $a GP $c GP
041 0 $a eng
050 4 $a QR185.8.I56
072 7 $a MJM $2 bicssc
072 7 $a MED083000 $2 bisacsh
082 0 4 $a 571.96 $2 23
090 $a QR185.8.I56 $b C559 2017
100 1 $a Chu, Cong-Qiu. $3 3218652
245 1 0 $a Targeting the IL-17 pathway in inflammatory disorders $h [electronic resource] / $c by Cong-Qiu Chu.
260 $a Cham : $b Springer International Publishing : $b Imprint: Adis, $c 2017.
300 $a xv, 102 p. : $b ill., digital ; $c 24 cm.
520 $a This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.
650 0 $a Interleukins. $3 2194691
650 0 $a Inflammation. $3 662994
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Rheumatology. $3 894494
650 2 4 $a Pharmacotherapy. $3 1978501
650 2 4 $a Primary Care Medicine. $3 894341
650 2 4 $a Public Health. $3 624351
650 2 4 $a Dermatology. $3 829009
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-28040-0
950 $a Medicine (Springer-11650)